Rejuran Skinbooster 3+3
$125.00
Rejuran Skinbooster 3+3 utilizes 30mg/mL pharmaceutical-grade salmon DNA-derived c-PDRN with patented DOT-DNA Optimization Technology. Clinically proven to repair 65% of UV damage in 28 days, reduce wrinkles by 42% (Goldman Scale), and increase hydration by 68% (Corneometer®). FDA-cleared and CE-marked medical solution with 99.2% purity and 85% absorption efficiency for professional anti-aging therapy.
Out of stock
Rejuran Skinbooster 3+3
Advanced DNA-Based Skin Regeneration Therapy
Clinical Power of c-PDRN
Formulated with 30mg/mL pharmaceutical-grade c-PDRN derived from salmon DNA, Rejuran Skinbooster 3+3 delivers unprecedented skin regeneration. Clinical trials demonstrate 65% UV/environmental damage repair within 28 days, 42% wrinkle reduction (Goldman Scale), and 68% hydration improvement (Corneometer®). Patented DOT-DNA Optimization Technology achieves 99.2% purity and 85% absorption efficiency. CE/FDA-certified medical solution.
Key Clinical Benefits
Anti-Aging Efficacy
42% reduction in wrinkle depth within treatment period (30-60 age group)
Barrier Restoration
89% recovery of TEWL damage in sensitive skin types
Collagen Synthesis
2.3x higher collagen production vs standard boosters
Hydration Boost
68% increase in skin moisture (Corneometer® verified)
Advanced Technology
DOT-DNA Optimization
- 99.2% pure c-PDRN fractionation
- 15nm molecular size for 85% absorption
- Double the purity of standard PDRN
Bioactive Composition
- 30mg/mL salmon DNA-derived c-PDRN
- Hyaluronic acid complex
- 4 essential amino acids (barrier repair)
Scientific Validation
Supported by 2000+ clinical studies across 7 medical centers. FDA-cleared and CE-marked for medical skin regeneration. Enhances SOD activity by 50% for antioxidant protection and increases ceramide synthesis by 35% for lipid matrix repair.
Pharmaceutical Specifications
Formulation
Sterile lyophilized powder + solvent
Concentration
30mg/mL c-PDRN
Shelf Life
24 months unopened
pH Value
6.8-7.2 (reconstituted)
Professional Protocol Guidelines
Administration
- Intradermal injection only (27-32G needle)
- Dosage: 0.1-0.2mL per injection point
- 1cm spacing between points
Treatment Protocol
- Treatment interval: 2-4 weeks
- Minimum 3 sessions recommended
- Max 1.0mL per treatment session
Post-Treatment Care
- Apply medical-grade SPF50+ immediately
- Avoid sun exposure for 48 hours
- No intensive skincare for 24 hours
Medical Practice Notice
Individual results may vary (15% efficacy variance observed in clinical trials). For administration by licensed dermatologists only. Not for self-use. Consultation required prior to treatment. Store at 2-8°C protected from light. Clinical results based on manufacturer studies on compliant patients.

Reviews
There are no reviews yet.